Skip to content

Clinical trials

Phase 1/2 Endometrial Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 1/2 Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20161
20171
20181
20191
20202
20213
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Active, not recruiting4
Completed4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Centre de recherche du Centre hospitalier universitaire de Sherbrooke1
Eisai Inc.1
Eli Lilly and Company1
Esperas Pharma Inc.1
GlaxoSmithKline1
Klus Pharma Inc.1
LigaChem Biosciences, Inc.1
Marengo Therapeutics, Inc.1
Medicenna Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms14
Ovarian Neoplasms9
Colorectal Neoplasms7
Breast Neoplasms6
Neoplasms6
Uterine Cervical Neoplasms6
Carcinoma, Non-Small-Cell Lung4
Pancreatic Neoplasms4
Stomach Neoplasms4
Biliary Tract Neoplasms3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.